丹蒌片通过PI3K/Akt/mTOR激活血管外膜成纤维细胞自噬以对抗动脉粥样硬化损伤
丹蒌片是临床用于心血管疾病的中成药。本研究在ApoE-/-小鼠模型及人血管外膜成纤维细胞(HVAFs)中探讨其抗动脉粥样硬化(AS)机制。结果显示丹蒌片抑制斑块脂质蓄积与纤维化、改善血脂并降低炎症因子,并通过抑制PI3K/Akt/mTOR通路激活HVAFs自噬、抑制其增殖迁移侵袭,从而保护细胞对抗AS损伤。
要点
- 丹蒌片可抑制ApoE-/-小鼠动脉粥样硬化斑块的脂质蓄积与纤维化形成。
- 丹蒌片降低血清甘油三酯、胆固醇、低密度脂蛋白及IL-6、TNF-α水平。
- 丹蒌片经抑制PI3K/Akt/mTOR通路激活HVAFs自噬并抑制其增殖、迁移、侵袭。
核心结论
- 丹蒌片通过PI3K/Akt/mTOR介导的血管外膜成纤维细胞自噬,保护细胞对抗动脉粥样硬化所致损伤。
研究设计与样本
- 研究采用ApoE-/-小鼠动脉粥样硬化模型,并结合人血管外膜成纤维细胞(HVAFs)进行体外机制研究。
主要发现
- 油红O、Masson三色及H&E染色显示丹蒌片显著抑制动脉粥样硬化斑块组织的脂质蓄积和纤维化形成。
- 丹蒌片抑制ApoE-/-小鼠血清甘油三酯、胆固醇、低密度脂蛋白水平及炎症因子白细胞介素-6和肿瘤坏死因子-α水平。
- 丹蒌片通过抑制PI3K/Akt/mTOR通路抑制HVAFs的增殖、迁移和侵袭。
- Western blot显示丹蒌片处理降低HVAFs中p62表达并提高Beclin 1表达及LC3 I向LC3 II转化比值。
- 3-甲基腺嘌呤(自噬抑制剂)和雷帕霉素(自噬激活剂)在HVAFs中证实了自噬在丹蒌片治疗动脉粥样硬化中的作用。
临床怎么用
- 丹蒌片可能通过调控PI3K/Akt/mTOR通路激活血管外膜成纤维细胞自噬,为动脉粥样硬化相关心血管疾病的治疗提供实验依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Danlou tablet (DLT), a commercial Chinese patent medicine, has been widely used to treat cardiovascular diseases for many years. Atherosclerosis (AS) is the leading cause of cardiovascular disease. Increasing evidence indicates that autophagy plays a vital role in the development of AS. Here we investigated whether DLT could activate autophagy to improve AS and further clarified its underlying mechanisms. In an ApoE-/- mice model, the results of Oil red O, Masson's trichrome, and H&E staining techniques showed that DLT significantly inhibited lipid accumulation and fibrosis formation in atherosclerotic plaque tissue. DLT also inhibited serum triglyceride, cholesterol, and low-density lipoprotein levels and suppressed serum levels of inflammatory factors interleukin-6 and tumor necrosis factor-α in ApoE-/- mice. Moreover, DLT suppressed proliferation, migration, and invasion of human vascular adventitial fibroblasts (HVAFs) by inhibiting the PI3K/Akt/mTOR pathway. In addition, western blot analysis showed that Danlou tablet treatment decreased the expression of p62 and increased Beclin 1 and LC3 I -to-LC3 II ratios in HVAFs. The role of autophagy in treating atherosclerosis by DLT is confirmed by 3-methyladenine (autophagy inhibitor) and rapamycin (autophagy activator) in HVAFs. In summary, DLT activated PI3K/Akt/mTOR-mediated autophagy of vascular adventitial fibroblasts to protect cells from damage caused by atherosclerosis.
引用
- Wang L, Wu T, Si C, et al. Danlou Tablet Activates Autophagy of Vascular Adventitial Fibroblasts Through PI3K/Akt/mTOR to Protect Cells From Damage Caused by Atherosclerosis. Front Pharmacol. 2021. PMID: 34867337. doi:10.3389/fphar.2021.730525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。